Evidence map›Paper›PMID 28435646›Full record

ArticleRare tumors2017

Osteosclerosis Secondary to Metastatic Oligodendroglioma.

Patrick R Maloney, Vitor Nagai Yamaki, Ravi Kumar, Derek Johnson, Christopher Hunt, Mark E Jentoft, Michelle Clarke

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Rare tumors, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Patrick R MaloneyDepartments of Neurosurgery, Mayo Clinic, College of Medicine, Rochester, MN, USA.
Vitor Nagai YamakiDepartments of Neurosurgery, Mayo Clinic, College of Medicine, Rochester, MN, USA.
Ravi KumarDepartments of Neurosurgery, Mayo Clinic, College of Medicine, Rochester, MN, USA.
Derek JohnsonNeurology, Mayo Clinic, College of Medicine, Rochester, MN, USA.
Christopher HuntNeuroradiology, Mayo Clinic, College of Medicine, Rochester, MN, USA.
Mark E JentoftAnatomic Pathology, Mayo Clinic, College of Medicine, Rochester, MN, USA.
Michelle ClarkeDepartments of Neurosurgery, Mayo Clinic, College of Medicine, Rochester, MN, USA.
Mayo Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This paper reviews a case of metastatic 1p/19q codeleted oligodendrioglioma causing diffuse osteosclerosis and pain. Primary central nervous system (CNS) tumors rarely metastasize outside the CNS, and metastatic oligodendroglioma is rarer still. The patient in this study had relief of pain after being treated with temozolomide. We discuss this rare presentation and potential treatment options, and review the literature in regards to metastatic oligodendrogliomas.

Indexed as

1p/19qMetastasisOligodendrogliomaOsteosclerosis

Identifiers

PMID28435646
PMCPMC5379227
OpenAlexW2604089893

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.